The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Or Yat Sun since 2014.
This trader's CIK number is 1571212.
At the time of last reporting, Or Yat Sun was the Chief Scientific Officer of Enanta Pharmaceuticals Inc. (stock ticker symbol ENTA).
Also see all insider trading activities at Enanta Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ENTA | 0 | $0 | 2,591 | $20,883 | 0 | $0 |
| 2023 | ENTA | 0 | $0 | 30,262 | $1,253,917 | 27,850 | $389,900 |
| 2021 | ENTA | 0 | $0 | 0 | $0 | 13,693 | $172,162 |
| 2020 | ENTA | 0 | $0 | 0 | $0 | 10,500 | $0 |
| 2019 | ENTA | 0 | $0 | 43,981 | $4,091,113 | 25,977 | $345,935 |
| 2017 | ENTA | 0 | $0 | 13,921 | $488,501 | 0 | $0 |
| 2016 | ENTA | 0 | $0 | 13,921 | $437,606 | 121,487 | $278,457 |
| 2015 | ENTA | 0 | $0 | 30,000 | $1,235,075 | 58,004 | $70,010 |
| 2014 | ENTA | 0 | $0 | 40,000 | $1,578,555 | 140,236 | $109,035 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-06 | ENTA | Sale | 2,591 | 8.06 | 20,883 |
| 2023-12-05 | ENTA | Sale | 2,412 | 9.63 | 23,227 |
| 2023-03-15 | ENTA | Option Ex | 13,925 | 14.00 | 194,950 |
| 2023-03-15 | ENTA | Sale | 13,925 | 44.19 | 615,345 |
| 2023-03-15 | ENTA | Option Ex | 13,925 | 14.00 | 194,950 |
| 2023-03-15 | ENTA | Sale | 13,925 | 44.19 | 615,345 |
| 2021-01-26 | ENTA | Option Ex | 13,693 | 12.57 | 172,162 |
| 2020-12-15 | ENTA | Option Ex | 5,250 | .00 | 0 |
| 2019-12-16 | ENTA | Option Ex | 5,250 | .00 | 0 |
| 2019-03-01 | ENTA | Sale | 10,000 | 103.58 | 1,035,789 |
| 2019-02-11 | ENTA | Option Ex | 25,977 | 13.32 | 345,935 |
| 2019-02-11 | ENTA | Sale | 27,684 | 89.88 | 2,488,154 |
| 2019-02-12 | ENTA | Sale | 6,297 | 90.07 | 567,170 |
| 2017-01-04 | ENTA | Sale | 13,921 | 35.09 | 488,501 |
| 2016-11-29 | ENTA | Sale | 13,921 | 31.43 | 437,606 |
| 2016-01-19 | ENTA | Option Ex | 42,922 | 2.54 | 109,150 |
| 2016-01-04 | ENTA | Option Ex | 78,565 | 2.15 | 169,307 |
| 2015-08-10 | ENTA | Sale | 3,750 | 42.96 | 161,100 |
| 2015-07-13 | ENTA | Sale | 3,750 | 46.40 | 174,000 |
| 2015-06-11 | ENTA | Sale | 3,750 | 42.47 | 159,266 |
| 2015-06-05 | ENTA | Sale | 10,750 | 42.02 | 451,661 |
| 2015-05-11 | ENTA | Sale | 8,000 | 36.13 | 289,048 |
| 2015-01-06 | ENTA | Option Ex | 58,004 | 1.21 | 70,010 |
| 2014-08-13 | ENTA | Sale | 5,000 | 39.76 | 198,795 |
| 2014-08-05 | ENTA | Option Ex | 11,149 | 1.29 | 14,415 |
| 2014-07-01 | ENTA | Sale | 5,000 | 42.59 | 212,935 |
| 2014-06-02 | ENTA | Sale | 5,000 | 37.76 | 188,800 |
| 2014-05-01 | ENTA | Sale | 5,000 | 36.76 | 183,795 |
| 2014-04-01 | ENTA | Sale | 10,000 | 39.95 | 399,450 |
| 2014-03-24 | ENTA | Sale | 10,000 | 39.48 | 394,780 |
| 2014-01-03 | ENTA | Option Ex | 129,087 | .73 | 94,620 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Or Yat Sun (Chief Scientific Officer of Enanta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.